FPS Pharma Engineers Custom Multi-Milling Station
The new pharmaceutical system integrates five milling types within a high-containment isolator.
Updated on Sept. 25, 2026 in Manufacturing

FPS Pharma has designed a custom multi-milling station for a pharmaceutical manufacturer to process highly potent compounds. The system features a high-containment OEB 6 isolator designed to operate in confined spaces.
Why it matters
This solution addresses the need for secure handling of potent compounds in limited areas. By integrating multiple milling technologies into a single unit, manufacturers can streamline production while maintaining safety.
The system includes one conical, one hammer, one pin, one loop, and one spiral jet mill. It maintains OEB 6 containment standards with performance targets reaching 10 ng/m³.
The players
FPS Pharma
An engineering company that specializes in the design and manufacture of pharmaceutical processing equipment.
Micronization Excellence Centre
A research facility used by FPS Pharma to test milling equipment and determine optimal processing configurations.
The details
The isolator includes an Airlock IN chamber, a milling chamber, and an Airlock OUT chamber, utilizing an inflatable EPDM gasket for door sealing. Engineers relied on data from the Micronization Excellence Centre to optimize the milling configurations and risk profiles.
Timeline
September 25, 2026: Article publication date.
Market Landscape
This development reflects the broader industry trend toward modular and multi-functional processing equipment in pharmaceutical manufacturing. It positions providers to compete by consolidating complex containment requirements into singular, space-efficient units.
For pharmaceutical manufacturers, this system reduces the infrastructure required to process potent compounds in confined spaces. It improves production safety and efficiency by providing a unified, certified containment solution.
The takeaway
Integrating multiple milling technologies into a single high-containment isolator helps bridge the gap between potency and space-constrained production. Facilities should prioritize modular design to ensure compliance with changing regulatory directives.
Further reading
Learn more about the latest innovations in Manufacturing.
Source note: This article includes information reported by Manufacturingchemist.



